Mesalamine
- Product NDC
- 31722-043
- 11-digit product format
- 317220043
- Labeler code
- 31722
- Product ID
- 31722-043_116b9d88-f7d4-f30e-e063-6394a90a3912
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mesalamine
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA216334
- Marketing category
- ANDA
- Marketing start
- 2024-02-05
- Substance
- MESALAMINE
- Active strength
- 1.2 g/1
- Pharmacologic classes
- Aminosalicylate [EPC], Aminosalicylic Acids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mesalamine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MESALAMINE | 1.2 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4Q81I59GXC |
| Rxcui | 686429 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 31722-043-05 | Mesalamine | 500 in 1 BOTTLE | TABLET, DELAYED RELEASE | 500 | | 1 |
| 31722-043-12 | Mesalamine | 120 in 1 BOTTLE | TABLET, DELAYED RELEASE | 120 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 31722-043 | MESALAMINE TABLET, DELAYED RELEASE [CAMBER PHARMACEUTICALS, INC.] | 1 | Current NDC, 2 package rows | 20240216_04ce2182-2e8c-4598-a269-550cfaddde6c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 31722-043-05 | 31722004305 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (31722-043-05) | 2024-02-05 | No | No | Current |
| 31722-043-12 | 31722004312 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (31722-043-12) | 2024-02-05 | No | No | Current |